Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Sales | 2,755,476 | 2,823,811 | 2,948,076 | 2,880,413 | 2,641,438 |
| Cost of Goods | 741,000 | 578,000 | 823,000 | 748,000 | 708,000 |
| Gross Profit | 2,014,000 | 1,812,000 | 2,280,000 | 2,132,000 | 2,075,000 |
| Operating Expenses | 1,236,000 | 2,053,000 | 1,472,000 | 1,463,000 | 1,324,000 |
| Operating Income | 778,476 | 192,811 | 653,076 | 669,413 | 609,438 |
| Other Income | -476 | -433,811 | 154,924 | -413 | 141,562 |
| Pre-tax Income | 778,000 | -241,000 | 808,000 | 669,000 | 751,000 |
| Income Tax | 203,000 | -154,000 | 219,000 | 181,000 | 203,000 |
| Net Income Continuous | 574,745 | -43,081 | 571,803 | 519,156 | 534,150 |
| Net Income Discontinuous | 0 | 626,081 | 17,364 | -31,149 | -232,626 |
| Net Income | $574,745 | $583,000 | $589,167 | $488,007 | $301,524 |
| EPS Basic Total Ops | 0.28 | 0.28 | 0.29 | 0.24 | 0.27 |
| EPS Basic Continuous Ops | 0.28 | -0.02 | 0.28 | 0.25 | 0.26 |
| EPS Basic Discontinuous Ops | N/A | 0.30 | 0.01 | -0.02 | -0.11 |
| EPS Diluted Total Ops | 0.28 | 0.28 | 0.29 | 0.24 | 0.15 |
| EPS Diluted Continuous Ops | 0.28 | -0.02 | 0.28 | 0.25 | 0.26 |
| EPS Diluted Discontinuous Ops | N/A | 0.30 | 0.01 | -0.02 | -0.11 |
| EBITDA(a) | $778,476 | $192,811 | $653,076 | $669,413 | $609,438 |